Panbela Therapeutics, Inc. (PBLA) DCF Valuation

Panbela Therapeutics, Inc. (PBLA) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

Panbela Therapeutics, Inc. (PBLA) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Engineered for accuracy, our (PBLA) DCF Calculator empowers you to evaluate Panbela Therapeutics, Inc. valuation using real-world financial data and offers complete flexibility to modify all key parameters for improved projections.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA -4.4 -5.1 -10.6 -34.8 -51.3 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 100 100 100 100 100 100
Depreciation .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 100 100 100 100 100 100 100
EBIT -4.4 -5.2 -10.6 -34.8 -51.3 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 100 100 100 100 100 100
Total Cash 2.4 9.0 11.9 1.3 2.6 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .4 .3 .3 .0 .2
Account Receivables, % 100 100 100 100 100
Inventories .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 100 100 100 100 100 100 100
Accounts Payable .6 .6 .6 2.9 9.9 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 100 100 100 100 100 100 100
Capital Expenditure .0 .0 .0 -.7 .0 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 100 0 0 0 0 0
Tax Rate, % 0.73087 0.73087 0.73087 0.73087 0.73087 0.73087 0.73087 0.73087 0.73087 0.73087
EBITAT -4.1 -4.9 -10.1 -34.7 -50.9 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -3.9 -4.9 -10.0 -32.8 -44.0 -9.8 .0 .0 .0 .0
WACC, % 4.17 4.19 4.25 4.44 4.42 4.29 4.29 4.29 4.29 4.29
PV UFCF
SUM PV UFCF -9.4
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -9
Net Debt 3
Equity Value -12
Diluted Shares Outstanding, MM 0
Equity Value Per Share -110,133.35

What You Will Get

  • Pre-Filled Financial Model: Panbela Therapeutics' actual data facilitates accurate DCF valuation.
  • Full Forecast Control: Modify revenue growth, profit margins, WACC, and other essential drivers.
  • Instant Calculations: Automatic updates provide real-time results as you make adjustments.
  • Investor-Ready Template: A polished Excel file crafted for high-quality valuation.
  • Customizable and Reusable: Designed for adaptability, allowing repeated use for comprehensive forecasts.

Key Features

  • Comprehensive PBLA Data: Pre-filled with Panbela Therapeutics’ historical performance metrics and future growth projections.
  • Customizable Financial Inputs: Modify revenue forecasts, operating margins, discount rates, tax assumptions, and capital investments.
  • Adaptive Valuation Framework: Real-time updates to Net Present Value (NPV) and intrinsic value based on user-defined parameters.
  • Scenario Analysis: Develop various forecasting scenarios to evaluate different potential valuation results.
  • User-Centric Interface: Intuitive, organized, and crafted for both seasoned professionals and newcomers.

How It Works

  • Download: Obtain the comprehensive Excel file featuring Panbela Therapeutics, Inc. (PBLA) financial data.
  • Customize: Tailor your forecasts, such as revenue growth, EBITDA %, and WACC.
  • Update Automatically: Watch as intrinsic value and NPV calculations refresh in real-time.
  • Test Scenarios: Generate various projections and instantly analyze the results.
  • Make Decisions: Leverage the valuation findings to inform your investment choices.

Why Choose This Calculator?

  • Designed for Experts: A sophisticated tool utilized by researchers, investors, and financial analysts.
  • Comprehensive Data: Panbela Therapeutics, Inc. (PBLA) historical and projected financials included for precision.
  • Flexible Scenario Analysis: Effortlessly model various forecasts and assumptions.
  • Insightful Outputs: Automatically computes intrinsic value, NPV, and essential financial metrics.
  • User-Friendly: Detailed instructions guide you seamlessly through the calculation process.

Who Should Use Panbela Therapeutics, Inc. (PBLA)?

  • Investors: Gain insights into innovative cancer therapies and make informed investment choices.
  • Healthcare Analysts: Utilize comprehensive data to analyze market trends and company performance.
  • Consultants: Tailor presentations and reports with up-to-date information on therapeutic developments.
  • Biotech Enthusiasts: Enhance your knowledge of cutting-edge treatments through real-world case studies.
  • Educators and Students: Leverage it as a resource for learning about biotechnology and pharmaceutical advancements.

What the Template Contains

  • Historical Data: Includes Panbela Therapeutics, Inc.'s (PBLA) past financials and baseline forecasts.
  • DCF and Levered DCF Models: Detailed templates to calculate Panbela Therapeutics, Inc.'s (PBLA) intrinsic value.
  • WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
  • Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
  • Quarterly and Annual Statements: A complete breakdown of Panbela Therapeutics, Inc.'s (PBLA) financials.
  • Interactive Dashboard: Visualize valuation results and projections dynamically.

No products were found matching.